Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis.
The synthetic retinoid N-(4-hydroxyphenyl)retinamide (4HPR) exhibits anticancer activity in vivo and triggers apoptosis in transformed cells in vitro. Thus, apoptosis induction is acknowledged as a mechanistic underpinning for 4HPR's cancer preventive and therapeutic effects. Apoptosis induction by 4HPR is routinely preceded by and dependent on the production of reactive oxygen species (ROS) in transformed cells. Very little evidence exists, outside the possible involvement of the mitochondrial electron transport chain or the plasma membrane NADPH oxidase complex, that would pinpoint the predominant site of 4HPR-induced ROS production in transformed cells. Here, we investigated the role of dihydroorotate dehydrogenase (DHODH; an enzyme associated with the mitochondrial electron transport chain and required for de novo pyrimidine synthesis) in 4HPR-induced ROS production and attendant apoptosis in transformed skin and prostate epithelial cells. In premalignant prostate epithelial cells and malignant cutaneous keratinocytes the suppression of DHODH activity by the chemical inhibitor teriflunomide or the reduction in DHODH protein expression by RNA interference markedly reduced 4HPR-induced ROS generation and apoptosis. Conversely, colon carcinoma cells that lacked DHODH expression were markedly resistant to the pro-oxidant and cytotoxic effects of 4HPR. Together, these results strongly implicate DHODH in 4HPR-induced ROS production and apoptosis.
Hail
Numsen
N
Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA. Numsen.Hail@UCDenver.edu
Chen
Ping
P
Kepa
Jadwiga J
JJ
Bushman
Lane R
LR
Shearn
Colin
C
D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D002277:Carcinoma / Q000201:enzymology* / Q000473:pathology / Q000503:physiopathology; D002461:Cell Line, Transformed; D045744:Cell Line, Tumor; D003110:Colonic Neoplasms / Q000201:enzymology* / Q000473:pathology / Q000503:physiopathology; D003437:Crotonates / Q000494:pharmacology; D000090722:Dihydroorotate Dehydrogenase; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D017313:Fenretinide / Q000494:pharmacology; D006801:Humans; D006885:Hydroxybutyrates; D008297:Male; D009570:Nitriles; D044925:Oxidoreductases Acting on CH-CH Group Donors / Q000235:genetics / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000201:enzymology* / Q000473:pathology / Q000503:physiopathology; D034741:RNA, Small Interfering / Q000235:genetics; D017382:Reactive Oxygen Species / Q000378:metabolism; D012867:Skin / Q000473:pathology; D014052:Toluidines / Q000494:pharmacology
D003437:Crotonates; D000090722:Dihydroorotate Dehydrogenase; D006885:Hydroxybutyrates; D009570:Nitriles; D034741:RNA, Small Interfering; D017382:Reactive Oxygen Species; D014052:Toluidines; D017313:Fenretinide; C527525:teriflunomide; D044925:Oxidoreductases Acting on CH-CH Group Donors
J Biol Chem. 1975 Jun 10;250(11):4322-6
165196
Int J Cancer. 2006 Dec 15;119(12):2803-11
17044020
Prostate. 1997 Oct 1;33(2):97-104
9316650
Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1293-301
11142414
Int J Oncol. 2007 Mar;30(3):679-87
17273769
Biochemistry. 1996 Jan 30;35(4):1270-3
8573583
AIDS. 2000 Sep 29;14(14):2137-44
11061655
Apoptosis. 2006 Jun;11(6):889-904
16547589
J Biol Chem. 2004 Aug 6;279(32):33035-8
15096496
Apoptosis. 2006 Oct;11(10):1677-94
16850162
Mol Cancer Ther. 2009 Feb;8(2):366-75
19174558
Mol Carcinog. 2002 Jan;33(1):16-24
11807954
Apoptosis. 2009 Jul;14(7):849-63
19421858
Int MS J. 2008 Jun;15(2):62-8
18782502
Oncogene. 1999 Nov 4;18(46):6380-7
10597238
Cell Mol Life Sci. 2010 Mar;67(5):807-16
19941060
Mol Pharmacol. 1999 Mar;55(3):403-10
10051523
Cancer Res. 2008 Jun 1;68(11):4416-23
18519704
Anal Biochem. 1987 Feb 15;161(1):32-8
3578785
J Nutr. 2007 Apr;137(4):879-84
17374648
J Biol Chem. 2001 Dec 7;276(49):45614-21
11546781
Apoptosis. 2004 Jul;9(4):437-47
15192326
Br J Cancer. 2002 Jun 17;86(12):1951-6
12085192
Cancer Res. 1990 Aug 1;50(15):4644-9
2164443